These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 28094

  • 1. Preliminary data on antiserotonin effects of oxatomide, a novel anti-allergic compound.
    Van Nueten JM, Xhonneux R, Janssen PA.
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):217-20. PubMed ID: 28094
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of 1-[3-[4-(diphenylmethyl)-1-priperazinyl]-propyl]-1,3-dihydro-2H-benzimidazol-2- one (oxatomide) on contraction of canine bronchial muscle].
    Fujii K, Yonehara S, Takasugi S, Ueda T, Mukai M.
    Nihon Heikatsukin Gakkai Zasshi; 1983 Feb; 19(1):47-54. PubMed ID: 6141314
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacology of the new H1-receptor antagonist setastine hydrochloride.
    Porszász J, Varga F, Porszász KG, Szolscányi J, Barthó L, Petöcz L, Kápolnai L.
    Arzneimittelforschung; 1990 Dec; 40(12):1340-5. PubMed ID: 1982751
    [Abstract] [Full Text] [Related]

  • 6. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
    Poizot A, Dumez D, Ferrandon P, Lefournier C, Michel A, Armstrong JM.
    Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacological studies on oxatomide: (6) Effect on the peripheral organs].
    Ohmori K, Ishii H, Shuto K, Nakamizo N.
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):79-104. PubMed ID: 6133821
    [Abstract] [Full Text] [Related]

  • 8. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B.
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacological actions of oxatomide (KW-4354). 3. Actions on experimental asthma and Schultz-Dale reaction].
    Ohmori K, Ishii H, Takei Y, Shuto K, Nakamizo N.
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):481-93. PubMed ID: 6131021
    [Abstract] [Full Text] [Related]

  • 10. Oxatomide and derivatives as inhibitors of mediator release from a mast cell model. Structure-activity relationships.
    Paulussen JJ, Fischer MJ, Roelofsen EP, Horbach DA, de Mol NJ, Janssen LH.
    Arzneimittelforschung; 1996 May; 46(5):496-501. PubMed ID: 8737634
    [Abstract] [Full Text] [Related]

  • 11. In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound.
    Van Wauwe J, Awouters F, Neimegeers CJ, Janssens F, Van Nueten JM, Janssen PA.
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):39-51. PubMed ID: 6114717
    [Abstract] [Full Text] [Related]

  • 12. Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action.
    Nijkamp FP, Folkerts G, Beetens JR, De Clerck F.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):111-8. PubMed ID: 2571942
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacological studies on oxatomide (KW-4354): (2) Effect on the experimental models of the type 1-type 4 allergic reactions].
    Ohmori K, Ishii H, Hirayama T, Shuto K, Nakamizo N.
    Nihon Yakurigaku Zasshi; 1982 Sep; 80(3):261-70. PubMed ID: 6130033
    [Abstract] [Full Text] [Related]

  • 14. Antianaphylactic and antihistaminic activity of the non-steroidal anti-inflammatory compound nimesulide in guinea-pig.
    Berti F, Rossoni G, Buschi A, Robuschi M, Villa LM.
    Arzneimittelforschung; 1990 Sep; 40(9):1011-6. PubMed ID: 1981969
    [Abstract] [Full Text] [Related]

  • 15. Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators.
    Fukuda T, Morimoto Y, Iemura R, Kawashima T, Tsukamoto G, Ito K.
    Arzneimittelforschung; 1984 Sep; 34(7):801-5. PubMed ID: 6149754
    [Abstract] [Full Text] [Related]

  • 16. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals.
    Ishii K, Yakuo I, Seto Y, Kita A, Nakamura H, Nishikawa Y.
    Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286
    [Abstract] [Full Text] [Related]

  • 17. Dissociation between central and peripheral antihistamine activities of the new antiallergic agent N-[4-[4-(diphenylmethyl)-1-piperazinyl]-butyl]-3-(6-methyl-3-pyridyl) acrylamide in rats and monkeys.
    Ishii K, Yakuo I, Nakagawa H, Nakamura H.
    Arzneimittelforschung; 1993 Jun; 43(6):668-71. PubMed ID: 8102529
    [Abstract] [Full Text] [Related]

  • 18. [Antiserotonin and antihistaminic properties of dialkylaminoalkyl derivatives of 2-methyl-5-oxyindole].
    Latypova SV, Mashkovskiĭ MD.
    Farmakol Toksikol; 1967 Jun; 30(5):604-8. PubMed ID: 4386333
    [No Abstract] [Full Text] [Related]

  • 19. On the antiserotonin activity of 6-acetamido-3(3-(4-phenyl-1-piperazinyl)-propyl)-284(1h,3h)-quinazolinedione-maleate (MA 1420).
    Hong E.
    Arzneimittelforschung; 1973 Dec; 23(12):1726-8. PubMed ID: 4801682
    [No Abstract] [Full Text] [Related]

  • 20. Antitussive effect of oxatomide on citric acid-induced cough in conscious guinea pig. Preliminary communication.
    Braga PC, Bossi R, Piatti G, Dal Sasso M.
    Arzneimittelforschung; 1993 May; 43(5):550-3. PubMed ID: 8101081
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.